TrialAutopsyBuilt by Jawad Momani (Pwnedl0l)

Autopsy report · NCT06703216

Pre-emptive Anakinra for Cytokine Event Reduction

Cause of deathRegulatory or ethics Automatic label, confidence 0.9, unverified. How labels are made.
“The trial has been stopped pending FDA approval of modifications to the trial protocol.”

The sponsor’s own words in the registry.

Life of this trial

2024202520262027Registered2024-11-18Withdrawn (as of)2026-08-13Planned start2026-10 (planned)

Vital statistics

Status
Withdrawn
Phase
Phase 1, Phase 2
Sponsor
Kevin McNerney
Sponsor type
University, hospital or other
Conditions
B-Acute Lymphoblastic Leukemia; CAR-T Cell Therapy; Cytokine Release Syndrome; Immune Effector Cell Associated Neurotoxicity Syndrome; Immune Effector Cell Associated Hemophagocytic Lymphohistiocytosis-like Syndrome
Interventions
Anakinra (Kineret®)
Participants
0
Sites
1
Countries
United States

Trials that died the same way

Look deeper

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.